Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin versus pramipexole and placebo in restless legs syndrome
NL-OMON35592Phase 3Active, not recruiting
- Sponsor
- Pfizer
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin and pramipexole in restless legs syndrome (RLS), sponsored by Pfizer. Primary endpoints: Change from baseline in International Restless Legs Scale total score, Clinical Global Impression - Improvement responder rate and 1 more. Started Jan 2010; status: active, not recruiting.
02
Drugs
pregabalinpramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NL-OMON35592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35592.